Nicotinic Receptors, Amyloid-β, and Synaptic Failure in Alzheimer’s Disease

被引:0
|
作者
Sofia Jürgensen
Sergio T. Ferreira
机构
[1] Federal University of Rio de Janeiro,Institute of Medical Biochemistry
来源
Journal of Molecular Neuroscience | 2010年 / 40卷
关键词
Alzheimer’s disease; Nicotinic receptors; Amyloid-β;
D O I
暂无
中图分类号
学科分类号
摘要
Dysfunctional cholinergic transmission is thought to underlie, at least in part, memory impairment and cognitive deficits in Alzheimer’s disease (AD). However, it is still unclear whether this is a consequence of the loss of cholinergic neurons and elimination of nicotinic acetycholine receptors (nAChRs) in AD brain or of a direct impact of molecular interactions of the amyloid-β (Aβ) peptide with nAChRs, leading to dysregulation of receptor function. This review examines recent progress in our understanding of the roles of nicotinic receptors in mechanisms of synaptic plasticity, molecular interactions of Aβ with nAChRs, and how Aβ-induced dysregulation of nicotinic receptor function may underlie synaptic failure in AD.
引用
收藏
页码:221 / 229
页数:8
相关论文
共 50 条
  • [31] The role of metallobiology and amyloid-ß peptides in Alzheimer's disease
    Roberts, Blaine R.
    Ryan, Timothy M.
    Bush, Ashley I.
    Masters, Colin L.
    Duce, James A.
    JOURNAL OF NEUROCHEMISTRY, 2012, 120 : 149 - 166
  • [32] Biomarkers in Amyloid-β Immunotherapy Trials in Alzheimer’s Disease
    Kaj Blennow
    Harald Hampel
    Henrik Zetterberg
    Neuropsychopharmacology, 2014, 39 : 189 - 201
  • [33] The Dichotomy of Alzheimer's Disease Pathology: Amyloid-β and Tau
    Ashford, J. Wesson
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 68 (01) : 77 - 83
  • [34] Is Alzheimer's Disease a Result of Presynaptic Failure? Synaptic Dysfunctions Induced by Oligomeric β-Amyloid
    Nimmrich, Volker
    Ebert, Ulrich
    REVIEWS IN THE NEUROSCIENCES, 2009, 20 (01) : 1 - 12
  • [35] Amyloid flirting with synaptic failure: Towards a comprehensive view of Alzheimer's disease pathogenesis
    Marcello, Elena
    Epis, Roberta
    Di Luca, Monica
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 585 (01) : 109 - 118
  • [36] Influence of Comorbidity of Cerebrovascular Disease and Amyloid-β on Alzheimer's Disease
    Yassi, Nawaf
    Hilal, Saima
    Xia, Ying
    Lim, Yen Ying
    Watson, Rosie
    Kuijf, Hugo
    Fowler, Christopher
    Yates, Paul
    Maruff, Paul
    Martins, Ralph
    Ames, David
    Chen, Christopher
    Rowe, Christopher C.
    Villemagne, Victor L.
    Salvado, Olivier
    Desmond, Patricia M.
    Masters, Colin L.
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 73 (03) : 897 - 907
  • [37] S 24795 Limits β-Amyloid-α7 Nicotinic Receptor Interaction and Reduces Alzheimer's Disease-Like Pathologies
    Wang, Hoau-Yan
    Bakshi, Kalindi
    Shen, Changpeng
    Frankfurt, Maya
    Trocme-Thibierge, Caryn
    Morain, Philippe
    BIOLOGICAL PSYCHIATRY, 2010, 67 (06) : 522 - 530
  • [38] Perivascular drainage of amyloid-β peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease
    Weller, Roy O.
    Subash, Malavika
    Preston, Stephen D.
    Mazanti, Ingrid
    Carare, Roxana O.
    BRAIN PATHOLOGY, 2008, 18 (02) : 253 - 266
  • [39] Plasma Amyloid-β Forms in Alzheimer's Disease and Non-Alzheimer's Disease Patients
    Le Bastard, Nathalie
    Leurs, Judith
    Blomme, Walter
    De Deyn, Peter Paul
    Engelborghs, Sebastiaan
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 21 (01) : 291 - 301
  • [40] Allosteric modulation of nicotinic receptors as a treatment strategy for Alzheimer's disease
    Maelicke, A
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2000, 11 : 11 - 18